General Information
Revision date
2013-02-01
Product name
- CS-953
Icons in SDS
Company Information
company name
Hanco Ink, LLC
Section 2
Principle Routes of Exposure
Ingestion, Skin contact, Eye contact, Inhalation.
Medical Conditions Generally Aggravated by Exposure
Eye disease, Skin disease including eczema and sensitization, Respiratory disease including asthma and bronchitis. Immediate (Acute) Health Effects: Inhalation: Can cause minor respiratory irritation, dizziness, weakness, fatigue, nausea, and headache. Harmful! Can cause systemic damage (see "Target Organs) Skin Contact: Can cause minor skin irritation, defatting, and dermatitis. Eye Contact: Can cause minor irritation, tearing and reddening. Skin Absorption: Minimal hazard in normal industrial use. Ingestion: Irritating to mouth, throat, and stomach. Can cause abdominal discomfort, nausea, vomiting and diarrhea. Small amounts of this product aspired (breathing in of liquid into the lungs) into the respiratory system during ingestion or vomiting may cause mild to severe pulmonary injury, possibly progressing to death. Target Organ Acute Toxicity: Eyes, Skin, Respiratory system, Central nervous system stimulation. Long-Term (Chronic) Health Effects: Carcinogenicity: Contains a substance that is a possible cancer hazard based on high dose animal studies. An extensive study in rats and mice carried out by the Cosmetic, Toiletry, & Fragrance Association (CTFA) for the Food & Drug Administration (FDA) on D & C Red #9 (Pigment Red 53:1), indicates absence of statistically significant carcinogenic effects at both high and low doses. In contrast, earlier feeding study in rats and mice carried out for The National Toxicology Program (NTP) by Battelle Laboratories, indicates a statistically significant carcinogenic effect in the spleen of male rats at high dose levels. Not listed as a carcinogen by: ACGIH, or OSHA. Reproductive and Developmental No data available to indicate product or any components present at greater than 0.1% may cause birth defects. Toxicity: Mutagenicity: No data available to indicate product or any components present at greater than 0.1% is mutagenic or genotoxic. Inhalation: Upon prolonged and/or repeated exposure, can cause minor respiratory irritation, dizziness, weakness, fatigue, nausea, and headache. Prolonged or excessive inhalation may cause respiratory tract irritation. Skin Contact: Upon prolonged or repeated contact, can cause minor skin irritation, defatting, and dermatitis. Eye Contact: Upon prolonged or repeated contact, can cause minor irritation, tearing and reddening. Skin Absorption Upon prolonged or repeated exposure, minimal hazard in normal industrial use. No component(s) in this product are known to be absorbed through the skin. Target Organ Chronic Toxicity: Skin, Respiratory tract, Central nervous system stimulation. Supplemental Health Hazard Individuals with pre-existing eye and skin disorders can be at greater risk. Information: IV. FIRST AID Inhalation: Remove to fresh air. If breathing is difficult, have a trained individual administer oxygen. Seek medical advice if symptoms persist